Valuation Amgen Inc. Sao Paulo

Stocks

Market Closed - Sao Paulo Other stock markets 20:47:26 24/07/2026 BST			5-day change	1st Jan Change
68.26 ^BRL	+2.93%		+2.34%	+3.49%

07-24	Amgen submits new data to challenge FDA's proposal to withdraw Tavneos	RE
07-24	CuraTeQ Biologics Wins European Medicines Agency's Positive Opinion for Neulasta Biosimilar	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	126,718	140,139	154,142	140,103	176,250	202,952	-	-
Change	-	10.59%	9.99%	-9.11%	25.8%	15.15%	-	-
Enterprise Value (EV) ¹	151,990	169,779	207,811	188,229	221,725	244,624	239,711	234,434
Change	-	11.7%	22.4%	-9.42%	17.8%	10.33%	-2.01%	-2.2%
P/E	21.9x	21.7x	23.1x	34.5x	23x	24.7x	22.6x	21.7x
PBR	18.7x	38.3x	24.7x	23.8x	20.4x	19x	15.9x	13.1x
PEG	-	1.2x	7.36x	-0.9x	0.3x	3.46x	2.5x	5.42x
Capitalization / Revenue	4.88x	5.32x	5.47x	4.19x	4.8x	5.38x	5.25x	5.11x
EV / Revenue	5.85x	6.45x	7.37x	5.63x	6.03x	6.48x	6.2x	5.9x
EV / EBITDA	9.61x	10.5x	11.9x	9.13x	10.4x	11.4x	11.1x	10.9x
EV / EBIT	12.2x	13.3x	15.5x	12.5x	13.7x	14.8x	14.1x	13.4x
EV / FCF	18.1x	19.3x	28.2x	18.1x	27.4x	19.3x	15.9x	15.4x
FCF Yield	5.51%	5.17%	3.54%	5.52%	3.65%	5.19%	6.31%	6.5%
Dividend per Share ²	7.04	7.76	8.52	9	9.52	10.09	10.66	11.12
Rate of return	3.13%	2.95%	2.96%	3.45%	2.91%	2.68%	2.83%	2.96%
EPS ²	10.28	12.11	12.49	7.56	14.23	15.25	16.63	17.29
Distribution rate	68.5%	64.1%	68.2%	119%	66.9%	66.2%	64.1%	64.3%
Net sales ¹	25,979	26,323	28,190	33,424	36,751	37,756	38,690	39,746
EBITDA ¹	15,822	16,178	17,470	20,620	21,370	21,398	21,537	21,442
EBIT ¹	12,424	12,761	13,399	15,028	16,203	16,492	16,998	17,484
Net income ¹	5,893	6,552	6,717	4,090	7,711	8,219	8,851	9,284
Net Debt ¹	25,272	29,640	53,669	48,126	45,475	41,673	36,759	31,482
Reference price ²	224.97	262.64	288.02	260.64	327.31	376.04	376.04	376.04
Nbr of stocks (in thousands)	563,266	533,579	535,178	537,533	538,481	539,708	-	-
Announcement Date	07/02/22	31/01/23	06/02/24	04/02/25	03/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	35.7x	12.68x	26.75x	0.57%	1,067B
JOHNSON & JOHNSON	28.24x	6.45x	17.87x	2.04%	635B
ABBVIE INC.	33.87x	7.65x	15.73x	2.65%	458B
ROCHE HOLDING AG	19.22x	4.69x	11.57x	2.82%	347B
NOVARTIS AG	21.56x	5.71x	14.24x	2.81%	295B
ASTRAZENECA PLC	21.1x	4.45x	12.31x	1.98%	262B
NOVO NORDISK A/S	14.14x	5.26x	10.84x	3.54%	216B
GILEAD SCIENCES, INC.	-46.58x	5.59x	30.88x	2.55%	161B
PFIZER INC.	12.46x	3.06x	7.75x	7.02%	140B
Average	15.52x	6.17x	16.44x	2.89%	397.77B
Weighted average by Cap.	24.41x	7.84x	18.69x	2.12%